1. Home
  2. EDBL vs ONCO Comparison

EDBL vs ONCO Comparison

Compare EDBL & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

N/A

Current Price

$0.24

Market Cap

1.3M

ML Signal

N/A

Logo Onconetix Inc.

ONCO

Onconetix Inc.

N/A

Current Price

$1.05

Market Cap

1.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EDBL
ONCO
Founded
2020
2018
Country
United States
United States
Employees
95
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3M
1.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EDBL
ONCO
Price
$0.24
$1.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.2M
3.9M
Earning Date
05-15-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22.80
EPS
N/A
N/A
Revenue
N/A
$815,371.00
Revenue This Year
$68.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.09
52 Week High
$7.54
$6.73

Technical Indicators

Market Signals
Indicator
EDBL
ONCO
Relative Strength Index (RSI) 30.69 56.70
Support Level $0.18 $0.42
Resistance Level $0.30 $1.44
Average True Range (ATR) 0.03 0.10
MACD 0.03 0.00
Stochastic Oscillator 39.48 24.99

Price Performance

Historical Comparison
EDBL
ONCO

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. Company provides two principal product segments: (i) fresh produce, including cut herbs, hydroponic basil, potted herbs, and wheatgrass; and (ii) shelf-stable and refrigerated consumer packaged goods, including sports nutrition and nutraceuticals.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: